In vivo, HSC alleviated COPD symptoms in CS + LPS-induced mice, reducing TLR4/NF-κB/MAPK signaling pathways overactivation and smoking-associated factors. This evidence concerns the gene TLR4 and chronic obstructive pulmonary disease.